Show simple item record

dc.contributor.authorHoffman, Jeremy J.
dc.contributor.authorYadav, Reena
dc.contributor.authorSanyam, Sandip Das
dc.contributor.authorChaudhary, Pankaj
dc.contributor.authorRoshan, Abhishek
dc.contributor.authorSingh, Sanjay K.
dc.contributor.authorMishra, Sailesh K.
dc.contributor.authorArunga, Simon
dc.contributor.authorHu, Victor H.
dc.contributor.authorMacleod, David
dc.contributor.authorLeck, Astrid
dc.contributor.authorBurton, Matthew J.
dc.date.accessioned2024-03-01T12:03:39Z
dc.date.available2024-03-01T12:03:39Z
dc.date.issued2022
dc.identifier.citationHoffman, J. J., Yadav, R., Das Sanyam, S., Chaudhary, P., Roshan, A., Singh, S. K., ... & Burton, M. J. (2022). Delay in accessing definitive care for patients with microbial keratitis in Nepal. Frontiers in medicine, 9, 915293.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/3439
dc.description.abstractBackground: The aim of this study was to describe the health-seeking journey for patients with microbial keratitis (MK) in Nepal and identify factors associated with delay. Methods: Prospective cohort study where MK patients attending a large, tertiary-referral eye hospital in south-eastern Nepal between June 2019 and November 2020 were recruited. We collected demographic details, clinical history, and examination findings. Care-seeking journey details were captured including places attended, number of journeys, time from symptom onset, and costs. We compared “direct” with “indirect” presenters, analyzing for predictors of delay. Results: We enrolled 643 patients with MK. The majority (96%) self-referred. “Direct” attenders accounted for only 23.6% (152/643) of patients, the majority of “indirect” patients initially presented to a pharmacy (255/491). Over half (328/643) of all cases presented after at least 7 days. The total cost of care increased with increasing numbers of facilities visited (p < 0.001). Those living furthest away were least likely to present directly (p < 0.001). Factors independently associated with delayed presentation included distance >50km from the eye hospital [aOR 5.760 (95% CI 1.829–18.14, p = 0.003)], previous antifungal use [aOR 4.706 (95% CI 3.139–5.360)], and two or more previous journeys [aOR 1.442 (95% CI 1.111–3.255)]. Conclusions: Most patients visited at least one facility prior to our institution, with time to presentation and costs increasing with the number of prior journeys. Distance to the eye hospital is a significant barrier to prompt, direct presentation. Based on these findings, improving access to eye care services, strengthening referral networks and encouraging early appropriate treatment are recommended to reduce delay, ultimately improving clinical outcomes.en_US
dc.description.sponsorshipWellcome Trust (207472/Z/17/Z)en_US
dc.language.isoen_USen_US
dc.publisherFrontiers in medicineen_US
dc.subjectMicrobial keratitisen_US
dc.subjectFungal keratitisen_US
dc.subjectEpidemiologyen_US
dc.subjectHealth systemsen_US
dc.subjectNepalen_US
dc.subjectcorneaen_US
dc.titleDelay in accessing definitive care for patients with microbial keratitis in Nepalen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record